The 5-year outcome of multidrug resistant tuberculosis patients in the Cape Province of South Africa

Tropical Medicine and International Health

Volumn 1, Issue 5, 1996, Pages 718-722

  Schaaf, H S ^a,e   Botha, P ^b   Beyers, N ^a   Gie, R P ^a   Vermeulen, H A S ^a   Groenewald, P ^c   Coetzee, G J ^d   Donald, P R ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^e Medical School   (South Africa)

Author keywords

Contacts; Morbidity; Mortality; Multidrug resistant; Mycobacterium tuberculosis; Outcome

Indexed keywords

ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; SOUTH AFRICA; TREATMENT OUTCOME;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0029858232     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.1996.tb00100.x     Document Type: Article

References (13)

1. Centres for Disease Control (1992) National action plan to combat multidrug-resistant tuberculosis. Morbidity and Mortality Weekly Report 41 (RR 11), 1-47.
2. Department of National Health and Population Development (1988) Tuberculosis control programme 1987. Epidemiological Comments 15 (11), 1-36.
3. Department of National Health and Population Development (1991a) First national HIV survey of women attending antenatal clinics, South Africa, October/November 1990. Epidemiological Comments 18 (2) 35-45.
4. Department of National Health and Population Development (1991b) Notifiable medical conditions 1990. Epidemiological Comments 18 (2), 53-54.
5. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L & Horsburgh CR (1993) Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. New England Journal of Medicine 328, 527-532.
6. Grzybowski S & Enarson DA (1978) The fate of cases of pulmonary tuberculosis under various treatment programmes. Bulletin of the International Union Against Tuberculosis 53, 70-74.
7. Iseman MD (1993) Treatment of multidrug-resistant tuberculosis. New England Journal of Medicine 329, 784-791.
8. Jancik E, Zelenka M, Tousek J & Makova M (1963) Chemotherapy for patients with cultures resistant to streptomycin, isoniazid and PAS. Tubercle 44, 443-445.
9. Kent JH (1993) The epidemiology of multidrug-resistant tuberculosis in the United States. Medical Clinics of Northern America 77, 1391-1409.
10. Kleeberg HH, Blacklock Z, Boulahbal F, David HL et al. (1985) A simple method of testing the drug susceptibility of Mycobacterium tuberculosis: a report of an international collaborative study. Bulletin of the International Union Against Tuberculosis 60, 147-150.
11. Swanevelder JP (1990) Tuberculosis control programme - 1988. Epidemiological Comments 17, 3-12.
12. Telzak EE, Sepkowitz K, Alpert P, Mannheimer S et al. (1995) Multidrug-resistant tuberculosis in patients without HIV infection. New England Journal of Medicine 333, 907-911.
13. Weyer K, Groenewald P, Zwarenstein M & Lombard CJ (1995) Tuberculosis drug resistance in the Western Cape. South African Medical Journal 85, 499-504.